IP Library Patent Application 18986315
Patent Application
App. No. 18/986,315

Methods of Epigenetic Analysis

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/986,315
Abstract

The present invention provides for methods of epigenetic analysis. In some cases, the methods may include obtaining a sample comprising a nucleic acid sequence. In some cases, the nucleic acid sequence may comprise one or more epigenetic marks. The methods may include performing a sequencing. The methods may include distinguishing a hydroxymethylated base from a methylated base.

Claims (17)

1 - 96 . (canceled)

97 . A composition comprising a mixture of a methylcytosine dioxygenase, and nucleic acid comprising glucosylated 5-hydroxymethylcytosine.

98 . The composition of claim 97 , wherein said methylcytosine dioxygenase is a ten eleven translocation (TET) enzyme.

99 . The composition of claim 98 , wherein said TET enzyme comprises TET1, TET2, TET3, CXXC4, or a combination thereof.

100 . composition of claim 97 , wherein said mixture comprises a DNA methyltransferase.

101 . The composition of claim 100 , wherein said DNA methyltransferase is DNMT1.

102 . The composition of claim 97 , further comprising a glucose donor substrate.

103 . The composition of claim 102 , wherein said glucose donor substrate comprises uridine diphosphate glucose (UDPG).

104 . The composition of claim 97 , further comprising a buffer.

105 . The composition of claim 97 , further comprising 5-methylcytosine.

106 . The composition of claim 97 , further comprising a short interfering ribonucleic acid (siRNA).

107 . The composition of claim 106 , wherein the siRNA is selected from the group consisting of SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 48, SEQ ID NO: 49, SEQ ID NO: 52, SEQ ID NO: 53, SEQ ID NO: 70, SEQ ID NO: 74, SEQ ID NO: 75, SEQ ID NO: 78, SEQ ID NO: 79, SEQ ID NO: 82, SEQ ID NO: 83, SEQ ID NO: 86, SEQ ID NO: 98, and SEQ ID NO: 92.

108 . A method comprising using a methylcytosine dioxygenase to generate a 5-hydroxymethylcytosine.

109 . The method of claim 108 , wherein said methylcytosine dioxygenase is a ten eleven translocation (TET) enzyme.

110 . The method of claim 109 , wherein said TET enzyme comprises TET1, TET2, TET3, CXXC4, or a combination thereof.

111 . The method of claim 108 , further comprising using a DNA methyltransferase.

112 . The method of claim 111 , wherein said DNA methyltransferase is DNMT1.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2025
From: AGARWAL, SUNEET
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 070175/0090 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2025
From: RAO, ANJANA; TAHILIANI, MAMTA; KOH, KIAN PENG
To: IMMUNE DISEASE INSTITUTE, INC.
Reel/Frame 070175/0114 →
MERGER Recorded Feb 11, 2025
From: IMMUNE DISEASE INSTITUTE, INC.
To: CHILDREN'S HOSPITAL CORPORATION, THE
Reel/Frame 070175/0117 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2025
From: IYER, ARAVIND
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 070175/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2025
From: CHILDREN'S HOSPITAL CORPORATION, THE
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 070421/0794 →